brequinar has been researched along with Dermatitis Medicamentosa in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armand, JP; Bork, E; Dodion, P; Nieboer, C; Pinedo, HM; Schwartsmann, G; Seldenrijk, CA; ten Bokkel Huinink, WW; Vermorken, JB | 1 |
1 trial(s) available for brequinar and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Mucocutaneous side effects of Brequinar sodium. A new inhibitor of pyrimidine de novo biosynthesis.
Topics: Aged; Antineoplastic Agents; Biphenyl Compounds; Diarrhea; Drug Administration Schedule; Drug Eruptions; Drug Evaluation; Female; Humans; Male; Middle Aged; Mucous Membrane; Nausea; Neoplasms; Skin Ulcer; Stomatitis; Vomiting | 1989 |